119 related articles for article (PubMed ID: 38345887)
1. Outcomes Of Surgically Treated N2-Positive Non-Small Cell Lung Cancer.
Rei J; Castro P; Guerra M; Miranda J
Port J Card Thorac Vasc Surg; 2024 Feb; 30(4):23-29. PubMed ID: 38345887
[TBL] [Abstract][Full Text] [Related]
2. Comparison of mediastinal lymph node status and relapse pattern in clinical stage IIIA non-small cell lung cancer patients treated with neoadjuvant chemotherapy versus upfront surgery: A single center experience.
Savic M; Kontic M; Ercegovac M; Stojsic J; Bascarevic S; Moskovljevic D; Kostic M; Vesovic R; Popevic S; Laban M; Markovic J; Jovanovic D
Thorac Cancer; 2017 Sep; 8(5):393-401. PubMed ID: 28671758
[TBL] [Abstract][Full Text] [Related]
3. Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2).
Ma Q; Liu D; Guo Y; Shi B; Song Z; Tian Y
Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):342-8. PubMed ID: 20677562
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment clinical mediastinal nodal bulk and extent do not influence survival in N2-positive stage IIIA non-small cell lung cancer patients treated with trimodality therapy.
Lee H; Ahn YC; Pyo H; Kim B; Oh D; Nam H; Lee E; Sun JM; Ahn JS; Ahn MJ; Park K; Choi YS; Kim J; Zo JI; Shim YM
Ann Surg Oncol; 2014 Jun; 21(6):2083-90. PubMed ID: 24522994
[TBL] [Abstract][Full Text] [Related]
5. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
[TBL] [Abstract][Full Text] [Related]
6. Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection: A Systematic Review and Meta-analysis.
Xu YP; Li B; Xu XL; Mao WM
Medicine (Baltimore); 2015 Jun; 94(23):e879. PubMed ID: 26061306
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).
Couñago F; Montemuiño S; Martin M; Taboada B; Calvo-Crespo P; Samper-Ots MP; Alcántara P; Corona J; López-Guerra JL; Murcia-Mejía M; López-Mata M; Jové-Teixidó J; Chust M; Díaz-Díaz V; de Ingunza-Barón L; García-Cañibano T; Couselo ML; Del Cerro E; Moradiellos J; Amor S; Varela A; Puertas MM; Thuissard IJ; Sanz-Rosa D; de Dios NR
Clin Transl Oncol; 2019 Jun; 21(6):735-744. PubMed ID: 30430394
[TBL] [Abstract][Full Text] [Related]
8. Prospective phase II trial of preresection thoracoscopic mediastinal restaging after neoadjuvant therapy for IIIA (N2) non-small cell lung cancer: results of CALGB Protocol 39803.
Jaklitsch MT; Gu L; Demmy T; Harpole DH; D'Amico TA; McKenna RJ; Krasna MJ; Kohman LJ; Swanson SJ; DeCamp MM; Wang X; Barry S; Sugarbaker DJ;
J Thorac Cardiovasc Surg; 2013 Jul; 146(1):9-16. PubMed ID: 23768804
[TBL] [Abstract][Full Text] [Related]
9. Surgical outcomes after initial surgery for clinical single-station N2 non-small-cell lung cancer.
Hishida T; Yoshida J; Ohe Y; Aokage K; Ishii G; Nagai K
Jpn J Clin Oncol; 2014 Jan; 44(1):85-92. PubMed ID: 24203815
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant radiation therapy improves survival in stage IIIA (N2) non-small cell lung cancer with persistent N2 disease after neoadjuvant chemotherapy.
Komiya T; Takamori S; Wilding G
Radiother Oncol; 2022 Nov; 176():234-238. PubMed ID: 36192229
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Outcomes of Selected Patients with IIIA-N2 Non-small Cell Lung Cancer Receiving Upfront Surgical Resection.
Fu F; Sun W; Bai J; Deng C; Zheng D; Li Y; Zhang Y; Chen H
Ann Surg Oncol; 2023 Dec; 30(13):8261-8270. PubMed ID: 37644250
[TBL] [Abstract][Full Text] [Related]
12. Management of stage IIIA non-small cell lung cancer by thoracic surgeons in North America.
Veeramachaneni NK; Feins RH; Stephenson BJ; Edwards LJ; Fernandez FG
Ann Thorac Surg; 2012 Sep; 94(3):922-6; discussion 926-8. PubMed ID: 22742842
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy following induction therapy and surgery improves survival in N2-positive non-small cell lung cancer.
White AA; Lee DN; Mazzola E; Kucukak S; Polhemus E; Jaklitsch MT; Mentzer SJ; Wee JO; Bueno R; Swanson SJ
J Surg Oncol; 2021 Feb; 123(2):579-586. PubMed ID: 33259637
[TBL] [Abstract][Full Text] [Related]
14. Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2)
Xiong L; Li R; Sun J; Lou Y; Zhang W; Bai H; Wang H; Shen J; Jing B; Shi C; Zhong H; Gu A; Jiang L; Shi J; Fang W; Zhao H; Zhang J; Wang J; Ye J; Han B
Oncologist; 2019 Feb; 24(2):157-e64. PubMed ID: 30158288
[TBL] [Abstract][Full Text] [Related]
15. Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials.
Ichinose Y; Kato H; Koike T; Tsuchiya R; Fujisawa T; Shimizu N; Watanabe Y; Mitsudomi T; Yoshimura M;
Lung Cancer; 2001 Oct; 34(1):29-36. PubMed ID: 11557110
[TBL] [Abstract][Full Text] [Related]
16. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease.
Kim HK; Cho JH; Choi YS; Zo JI; Shim YM; Park K; Ahn MJ; Ahn YC; Kim K; Kim J
Lung Cancer; 2016 Jun; 96():56-62. PubMed ID: 27133751
[TBL] [Abstract][Full Text] [Related]
18. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival.
Bueno R; Richards WG; Swanson SJ; Jaklitsch MT; Lukanich JM; Mentzer SJ; Sugarbaker DJ
Ann Thorac Surg; 2000 Dec; 70(6):1826-31. PubMed ID: 11156079
[TBL] [Abstract][Full Text] [Related]
19. [Survival Analysis of 121 Stage N2-IIIa Non-small Cell Lung Cancer Patients
Treated with Surgery].
Yang H; Dai L; Li P; Shen L; Yan W; Fan M; Chen K
Zhongguo Fei Ai Za Zhi; 2015 Aug; 18(8):505-11. PubMed ID: 26302348
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society).
Couñago F; Rodriguez de Dios N; Montemuiño S; Jové-Teixidó J; Martin M; Calvo-Crespo P; López-Mata M; Samper-Ots MP; López-Guerra JL; García-Cañibano T; Díaz-Díaz V; de Ingunza-Barón L; Murcia-Mejía M; Alcántara P; Corona J; Puertas MM; Chust M; Couselo ML; Del Cerro E; Moradiellos J; Amor S; Varela A; Thuissard IJ; Sanz-Rosa D; Taboada B
Lung Cancer; 2018 Apr; 118():119-127. PubMed ID: 29571989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
